Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument.
about
The Interaction between the Immune System and Epigenetics in the Etiology of Autism Spectrum DisordersA Comprehensive Review of the (1)H-MRS Metabolite Spectrum in Autism Spectrum DisorderPrenatal stress and inhibitory neuron systems: implications for neuropsychiatric disordersγ-band abnormalities as markers of autism spectrum disordersThe role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.GABAergic signaling as therapeutic target for autism spectrum disordersDecreased left perisylvian GABA concentration in children with autism and unaffected siblingsDevelopmental origins of brain disorders: roles for dopamineProspective MEG biomarkers in ASD: pre-clinical evidence and clinical promise of electrophysiological signatures.The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interactGABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of AutismSynaptic proteins and receptors defects in autism spectrum disordersProton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.GABA estimation in the brains of children on the autism spectrum: measurement precision and regional cortical variationBrain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.In utero exposure to valproic acid changes sleep in juvenile rats: a model for sleep disturbances in autism.GABA-based evaluation of neurologic conditions: MR spectroscopy.GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders.Orientation-specific surround suppression in the primary visual cortex varies as a function of autistic tendency.Early-life seizures produce lasting alterations in the structure and function of the prefrontal cortex."Brain MR spectroscopy in autism spectrum disorder-the GABA excitatory/inhibitory imbalance theory revisited"GABA system dysfunction in autism and related disorders: from synapse to symptomsAltered resting perfusion and functional connectivity of default mode network in youth with autism spectrum disorder.Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI.Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders.Altered Dynamics of the fMRI Response to Faces in Individuals with Autism.Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS studyReduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.Role of Metabolic Genes in Blood Aluminum Concentrations of Jamaican Children with and without Autism Spectrum DisorderPathways to drug development for autism spectrum disorders.Exploring the multifactorial nature of autism through computational systems biology: calcium and the Rho GTPase RAC1 under the spotlight.Developing new pharmacotherapies for autism.GABAergic dysfunction in pediatric neuro-developmental disorders.What's in the pipeline? Drugs in development for autism spectrum disorder.The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic reviewConvergence of circuit dysfunction in ASD: a common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology.Beta-lactam antibiotics as a possible novel therapy for managing epilepsy and autism, a case report and review of literatureMetabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis.Sex differences in the glutamate signaling pathway in juvenile rats.
P2860
Q26741427-573C8608-F436-4313-B263-1CBDA65001B9Q26751201-3BE6CACB-EC8D-4C2C-8969-C2F9DABF5C66Q26829786-14DC16B3-374C-40CD-A8FB-43B47EDC271BQ26830642-98731F24-0FDB-4669-AE4C-D15A7995A4E1Q26998975-070E18E2-56C3-4792-9218-4B4CC7F3386EQ27013583-889D4A8D-4A8F-4E40-9A21-C3AEAD001722Q27013590-F7392812-5267-471C-9194-D0A17661A7BAQ27024247-0596437C-1848-4633-8276-E643373BAC5AQ28083480-4C523323-9DFD-479E-B601-40E12C7DBF61Q28388719-264F399A-2EB1-41BE-AE62-F3CF42E67C85Q28391720-360A337C-CE05-4EDF-B064-AF86220BF9A3Q30009298-2A322D53-B677-49F0-9AC8-FBC4450FD5E4Q30593705-64E760ED-87C8-4064-A951-349B6BDEC476Q30632847-3035CBEC-272E-4663-97F0-89B8F26EFF1DQ31090438-0379DFBF-AF49-4A1A-9ED2-2FC9796F9DB6Q33659830-E30DF301-CD86-4008-A258-6F05B89F48BDQ34125907-907DAD7D-9058-491A-A0F1-91CFC026F354Q34135715-7AF2EEAA-9B39-494F-88D7-405439812F6EQ34568690-4E90A45A-2F32-4A79-8478-8E32B62BC8B0Q34841071-8EC0B048-8F48-46E6-B4DC-2F57E0EFA87CQ35256963-E2AD8F90-0E60-4CD4-B984-5F1A8AE49805Q35764150-3C9A6069-EB72-461F-8792-F79BECA30BD9Q35770888-FBD37337-C507-421D-BA5E-BE56D0BA49B2Q36109842-586EA63E-F3B4-4D56-9FB3-E44E8A2E9863Q36123660-2B2D646F-728A-4934-BFDC-B84D5ED96EAEQ36146082-03435A4A-6466-4FAE-890C-4A54016481A9Q36447640-720813AD-42FA-43AE-A484-94FD140E19E9Q36632136-C0E58718-3C55-4686-A1D0-6988BB6B2FACQ37065273-96131F99-DE5E-4575-A20B-FE86197259B2Q37455717-B5E44EF3-A66C-431C-B471-691E2EAFAEB3Q37972081-9DAE1D22-1069-48F2-9F20-4B190428055FQ38086129-6BEE4B20-575A-486B-838B-31FDBA26B7D1Q38122448-D36233FC-FF97-4F38-A59B-A4780FF5F575Q38175971-FAA7BC6C-0F78-491D-AB15-B16B1BC3EBDCQ38193069-5614B9E0-96FF-460A-BB93-5184CBEB205FQ38247298-DA0B709A-B5DF-42B7-A275-030A1112E506Q38299791-DE3C26B6-5983-4149-8803-9887AA638DC8Q38376352-01CFC1C1-D6C7-49B7-809E-464656F93734Q38401864-0A4CF0E9-C4B7-4879-8DC6-A4D33E190E80Q38598320-415AEFFB-12E4-4424-A2F3-2ED77D2D419D
P2860
Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Non-invasive evaluation of the ...... a clinical 3 tesla instrument.
@en
Non-invasive evaluation of the ...... a clinical 3 tesla instrument.
@nl
type
label
Non-invasive evaluation of the ...... a clinical 3 tesla instrument.
@en
Non-invasive evaluation of the ...... a clinical 3 tesla instrument.
@nl
prefLabel
Non-invasive evaluation of the ...... a clinical 3 tesla instrument.
@en
Non-invasive evaluation of the ...... a clinical 3 tesla instrument.
@nl
P2093
P2860
P1476
Non-invasive evaluation of the ...... a clinical 3 tesla instrument.
@en
P2093
Ayumi Nose
Hiromu Nishitani
Hitoshi Kubo
Kenji Mori
Masafumi Harada
Masako M Taki
Tsuyoshi Matsuda
P2860
P2888
P304
P356
10.1007/S10803-010-1065-0
P407
P577
2011-04-01T00:00:00Z